CL-275838 is primarily investigated for its potential therapeutic applications in the field of neuroscience. It has shown promise as a selective ligand for certain receptors in the brain, which may help in the treatment of neurological disorders such as anxiety, depression, and schizophrenia. Researchers are exploring its ability to modulate neurotransmitter systems, potentially offering a new avenue for managing symptoms associated with these conditions. Additionally, its pharmacological properties are being studied for their role in enhancing cognitive functions and memory, which could be beneficial in addressing neurodegenerative diseases like Alzheimer's. Ongoing research aims to further understand its efficacy and safety profile for clinical use.